Welcome to our dedicated page for Translational Development Acquisition SEC filings (Ticker: TDACW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Translational Development Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Translational Development Acquisition's regulatory disclosures and financial reporting.
Schedule 13G filing overview
On 7 July 2025, Wolverine Asset Management LLC and affiliated entities filed a Schedule 13G disclosing a passive ownership position in RF Acquisition Corp II (Ticker: RFAIU). The filing was triggered by an event date of 30 June 2025 that pushed the group above the 5 % reporting threshold.
The Wolverine group reports beneficial ownership of 863,687 ordinary shares, representing 5.75 % of the SPAC’s 15,012,500 outstanding shares as of 12 May 2025. Voting and dispositive authority are held on a shared basis across the reporting persons; no sole authority is claimed.
- Reporting persons: Wolverine Asset Management LLC (investment adviser), Wolverine Holdings L.P. (parent), Wolverine Trading Partners Inc. (general partner), and principals Christopher L. Gust and Robert R. Bellick.
- All reporting persons are organized or resident in Illinois/United States.
- Form type: Schedule 13G, indicating a passive investment with no intent to influence control.
- The stake is held on behalf of Wolverine Flagship Fund Trading Limited, which is entitled to dividends and sale proceeds.
The disclosure adds a mid-sized institutional investor to the SPAC’s register but does not signal activist activity or a change in corporate strategy. Investors may view the filing as a modest vote of confidence in the issuer, yet the absolute stake size and passive classification suggest limited immediate market impact.
FAQ
What is the current stock price of Translational Development Acquisition (TDACW)?
